Hogyan válasszunk megfelelő szert? Új kérdések az áttétes melanoma kezelésében
The last few years brought about a complete paradigm-shift in the field of melanoma therapy: eight new drugs, including three immunooncologic, four targeted and one oncolytic virus, became available in the daily practice. These new treatments provide a significantly increased overall survival potent...
Elmentve itt :
Szerzők: | |
---|---|
Dokumentumtípus: | Cikk |
Megjelent: |
2016
|
Sorozat: | MAGYAR ONKOLÓGIA
60 No. 1 |
mtmt: | 3031710 |
Online Access: | http://publicatio.bibl.u-szeged.hu/13920 |
LEADER | 01348nab a2200205 i 4500 | ||
---|---|---|---|
001 | publ13920 | ||
005 | 20180923212216.0 | ||
008 | 180923s2016 hu o 0|| zxx d | ||
022 | |a 0025-0244 | ||
024 | 7 | |a 3031710 |2 mtmt | |
040 | |a SZTE Publicatio Repozitórium |b hun | ||
041 | |a zxx | ||
100 | 1 | |a Oláh Judit Magdolna | |
245 | 1 | 0 | |a Hogyan válasszunk megfelelő szert? Új kérdések az áttétes melanoma kezelésében |h [elektronikus dokumentum] / |c Oláh Judit Magdolna |
260 | |c 2016 | ||
300 | |a 17-21 | ||
490 | 0 | |a MAGYAR ONKOLÓGIA |v 60 No. 1 | |
520 | 3 | |a The last few years brought about a complete paradigm-shift in the field of melanoma therapy: eight new drugs, including three immunooncologic, four targeted and one oncolytic virus, became available in the daily practice. These new treatments provide a significantly increased overall survival potential for patients with metastatic melanoma. Choosing the optimal treatment for the individual patient, however, requires the careful evaluation of several patient- and drug-related factors, and poses a great challenge for the oncologists. This review summarizes the practical aspects of the selection of the optimal melanoma treatment. | |
700 | 0 | 1 | |a Gyulai Rolland Péter |e aut |
856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/13920/1/3031710_Olah_Magyonkol_2016_u.pdf |z Dokumentum-elérés |